Mycenax Biotech, Inc. engages in the research and development, manufacture, and sale of biopharmaceutical products. It offers new protein molecules and biosmilars. It provides contract development and manufacturing organization services including cell line development, process development, analytics and quality control, good manufacturing practice, aseptic fill and finish, and regulatory compliance services. The company was founded by Ching Ying Chen, Ching Chu Feng and Yi Hsu Huang on September 28, 2001 and is headquartered in Miaoli, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company